Last reviewed · How we verify
IDA - Ivermectin + DEC + albendazole
IDA - Ivermectin + DEC + albendazole is a Antiparasitic combination Small molecule drug developed by Medicines Development for Global Health. It is currently in Phase 3 development for Lymphatic filariasis (mass drug administration), Onchocerciasis (river blindness), Co-infections with multiple helminth and filarial species.
IDA is a triple-drug combination that paralyzes and kills parasitic worms through multiple mechanisms: ivermectin and DEC (diethylcarbamazine) target neuromuscular function in microfilariae, while albendazole disrupts microtubule formation in helminths.
IDA is a triple-drug combination that paralyzes and kills parasitic worms through multiple mechanisms: ivermectin and DEC (diethylcarbamazine) target neuromuscular function in microfilariae, while albendazole disrupts microtubule formation in helminths. Used for Lymphatic filariasis (mass drug administration), Onchocerciasis (river blindness), Co-infections with multiple helminth and filarial species.
At a glance
| Generic name | IDA - Ivermectin + DEC + albendazole |
|---|---|
| Sponsor | Medicines Development for Global Health |
| Drug class | Antiparasitic combination |
| Target | GABA-gated chloride channels (ivermectin); β-tubulin (albendazole); microfilarial motility (DEC) |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Parasitology |
| Phase | Phase 3 |
Mechanism of action
Ivermectin acts as a GABA-gated chloride channel agonist, causing paralysis in nematodes and arthropods. DEC immobilizes microfilariae and enhances immune-mediated clearance. Albendazole inhibits β-tubulin polymerization, disrupting microtubule assembly essential for parasite survival. The combination targets multiple parasite species and life stages simultaneously.
Approved indications
- Lymphatic filariasis (mass drug administration)
- Onchocerciasis (river blindness)
- Co-infections with multiple helminth and filarial species
Common side effects
- Headache
- Fever
- Pruritus
- Gastrointestinal disturbance (nausea, diarrhea)
- Lymphadenitis (from parasite death)
- Arthralgia/myalgia
Key clinical trials
- Moxidectin for LF, Cote d'Ivoire (DOLF) (PHASE3)
- Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis (PHASE2)
- Better Options for Lymphatic Filariasis Treatment (PHASE3)
- Safety and Efficacy of IDA for Onchocerciasis (PHASE2)
- Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE) (PHASE1)
- Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IDA - Ivermectin + DEC + albendazole CI brief — competitive landscape report
- IDA - Ivermectin + DEC + albendazole updates RSS · CI watch RSS
- Medicines Development for Global Health portfolio CI
Frequently asked questions about IDA - Ivermectin + DEC + albendazole
What is IDA - Ivermectin + DEC + albendazole?
How does IDA - Ivermectin + DEC + albendazole work?
What is IDA - Ivermectin + DEC + albendazole used for?
Who makes IDA - Ivermectin + DEC + albendazole?
What drug class is IDA - Ivermectin + DEC + albendazole in?
What development phase is IDA - Ivermectin + DEC + albendazole in?
What are the side effects of IDA - Ivermectin + DEC + albendazole?
What does IDA - Ivermectin + DEC + albendazole target?
Related
- Drug class: All Antiparasitic combination drugs
- Target: All drugs targeting GABA-gated chloride channels (ivermectin); β-tubulin (albendazole); microfilarial motility (DEC)
- Manufacturer: Medicines Development for Global Health — full pipeline
- Therapeutic area: All drugs in Infectious Disease / Parasitology
- Indication: Drugs for Lymphatic filariasis (mass drug administration)
- Indication: Drugs for Onchocerciasis (river blindness)
- Indication: Drugs for Co-infections with multiple helminth and filarial species
- Compare: IDA - Ivermectin + DEC + albendazole vs similar drugs
- Pricing: IDA - Ivermectin + DEC + albendazole cost, discount & access